5 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 26473751 | VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis. | 2016 Jan | 3 |
2 | 25385260 | A randomized, double-blind, placebo-controlled, twelve-week, dose-ranging study of decernotinib, an oral selective JAK-3 inhibitor, as monotherapy in patients with active rheumatoid arthritis. | 2015 Feb | 1 |
3 | 25762693 | VX-509 (decernotinib) is a potent and selective janus kinase 3 inhibitor that attenuates inflammation in animal models of autoimmune disease. | 2015 May | 3 |
4 | 24818516 | Selective JAK inhibitors in development for rheumatoid arthritis. | 2014 Aug | 1 |
5 | 23055694 | Kinase inhibitors: a new class of antirheumatic drugs. | 2012 | 1 |